| Epidemiology | Lifetime | 179 | US 93 | 99.78 |
| Infectious Diseases | Lifetime | 94 | US 49 | 99.71 |
| Health | Lifetime | 142 | US 86 | 99.16 |
| Microbiology | Lifetime | 88 | US 48 | 98.67 |
| Virology | Lifetime | 253 | US 148 | 95.06 |
| Parasitology | Lifetime | 416 | US 160 | 94.39 |
| Endocrinology | Lifetime | 608 | US 254 | 80.21 |
| Hepatology | Lifetime | 875 | US 325 | 79.72 |
| Health | 2021-2025 | 129 | US 56 | 96.74 |
| Infectious Diseases | 2021-2025 | 428 | US 172 | 91.23 |
| Parasitology | 2021-2025 | 224 | US 65 | 50.54 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 45 | US 13 | 99.73 |
| Vaccine Coverage and Hesitancy | Lifetime | 16 | US 7 | 99.69 |
| Cytomegalovirus and herpesvirus research | Lifetime | 39 | US 25 | 99.58 |
| Herpesvirus Infections and Treatments | Lifetime | 32 | US 24 | 99.58 |
| Virology and Viral Diseases | Lifetime | 19 | US 14 | 99.64 |
| Viral gastroenteritis research and epidemiology | Lifetime | 75 | US 46 | 99.65 |
| Parvovirus B19 Infection Studies | Lifetime | 25 | US 13 | 99.37 |
| Viral Infections and Immunology Research | Lifetime | 73 | US 39 | 99.26 |
| Bacterial Infections and Vaccines | Lifetime | 45 | US 21 | 99.38 |
| Respiratory viral infections research | Lifetime | 161 | US 90 | 99.26 |
| Influenza Virus Research Studies | Lifetime | 172 | US 84 | 99.00 |
| Virus-based gene therapy research | Lifetime | 344 | US 233 | 98.84 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 233 | US 104 | 98.80 |
| Rabies epidemiology and control | Lifetime | 86 | US 32 | 98.52 |
| Viral Infections and Outbreaks Research | Lifetime | 139 | US 74 | 98.48 |
| Pneumonia and Respiratory Infections | Lifetime | 355 | US 147 | 98.73 |
| vaccines and immunoinformatics approaches | Lifetime | 157 | US 88 | 97.98 |
| Immune responses and vaccinations | Lifetime | 94 | US 27 | 96.39 |
| Viral Infections and Vectors | Lifetime | 818 | US 372 | 97.68 |
| Animal Virus Infections Studies | Lifetime | 741 | US 324 | 96.96 |
| Poxvirus research and outbreaks | Lifetime | 159 | US 98 | 96.41 |
| COVID-19 epidemiological studies | Lifetime | 567 | US 174 | 96.36 |
| COVID-19 Impact on Reproduction | Lifetime | 245 | US 103 | 94.82 |
| Hepatitis Viruses Studies and Epidemiology | Lifetime | 352 | US 117 | 96.71 |
| Toxoplasma gondii Research Studies | Lifetime | 366 | US 159 | 95.93 |
| Syphilis Diagnosis and Treatment | Lifetime | 302 | US 147 | 95.00 |
| Infectious Encephalopathies and Encephalitis | Lifetime | 303 | US 118 | 91.77 |
| Bacillus and Francisella bacterial research | Lifetime | 867 | US 440 | 89.60 |
| Diphtheria, Corynebacterium, and Tetanus | Lifetime | 947 | US 305 | 76.71 |
| Whipple's Disease and Interleukins | Lifetime | 598 | US 174 | 63.01 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 331 | US 101 | 95.48 |
| Viral gastroenteritis research and epidemiology | 2021-2025 | 976 | US 302 | 88.18 |
| Virology and Viral Diseases | 2021-2025 | 343 | US 94 | 81.50 |
| Viral Infections and Outbreaks Research | 2021-2025 | 837 | US 240 | 79.16 |
| vaccines and immunoinformatics approaches | 2021-2025 | 773 | US 189 | 76.55 |
| Celiac Disease Research and Management | 2021-2025 | 697 | US 114 | 68.57 |